Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis

Lin Zhou, Kang Song, Wei LuoFrontiers in Endocrinology 2023 · DOI

TL;DR

This systematic review and meta-analysis confirms that circulating resistin levels are significantly elevated in patients with thyroid dysfunction compared to healthy individuals. Crucially, these levels drop following successful treatment, suggesting that resistin—an adipokine linked to inflammation and insulin resistance—may serve as a dynamic biomarker for the metabolic disturbances associated with thyroid disease.

What Problem Does This Paper Address?

The "crosstalk" between the thyroid gland and adipose (fat) tissue is a critical component of human metabolism. Thyroid hormones regulate energy expenditure and thermogenesis, while adipose tissue acts as an endocrine organ, secreting signaling molecules called adipokines.

One such adipokine is resistin. In humans, resistin is primarily secreted by macrophages and is known to promote inflammation and insulin resistance. Because thyroid dysfunction (both hyperthyroidism and hypothyroidism) profoundly alters metabolic rate and insulin sensitivity, researchers have long suspected a link between thyroid hormones and resistin levels. However, previous clinical studies yielded contradictory results—some showing high resistin in thyroid patients, others showing no difference or even lower levels. This paper aims to resolve these inconsistencies by pooling data from multiple studies to provide a definitive quantitative assessment.

Methods

The authors performed a systematic review and meta-analysis following the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) guidelines.

  • Search Strategy: They searched PubMed, Embase, and Cochrane databases for studies published up to June 2022.
  • Inclusion Criteria: The meta-analysis focused on observational studies of adult patients with various forms of thyroid dysfunction (hyperthyroidism, hypothyroidism, and subclinical versions) that measured serum or plasma resistin levels.
  • Quality Assessment: The authors used the Newcastle-Ottawa Scale (NOS) to evaluate the methodological quality of the included studies, ensuring the data was robust.
  • Statistical Analysis: They employed RevMan (v5.4) and R (v4.2.0) to calculate Mean Differences (MD) and 95% Confidence Intervals (CI). Because of the expected variability between different study populations, they primarily used random-effects models to synthesize the data.

Datasets

As a meta-analysis, the "dataset" consists of previously published clinical studies.

  • Scope: 14 studies were included, encompassing a total of 1,716 participants.
  • Geography: The studies spanned diverse regions, including North America, Europe, Asia, and Africa.
  • Clinical Categories: The data covered overt hyperthyroidism, overt hypothyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism.

Key Insights and Ideas

  • The Adipose-Thyroid Axis is Real: The study reinforces the idea that the hypothalamic-pituitary-thyroid (HPT) axis and adipose tissue are biochemically linked. Resistin appears to be a key mediator in this relationship.
  • Hyperthyroidism has the Strongest Link: The association with elevated resistin was significantly stronger in patients with hyperthyroidism than in those with hypothyroidism. This suggests that high levels of thyroid hormones (T3/T4) may more aggressively stimulate resistin production or secretion.
  • Resistin as a "State" Marker: Because resistin levels decreased significantly after patients received treatment (surgery, drugs, or radioactive iodine), it suggests that elevated resistin is a consequence of the thyroid-dysfunctional state rather than a fixed genetic trait.
  • Correlation with FT3: The researchers found a significant positive correlation ($r = 0.27578$) between resistin and free triiodothyronine (FT3), the most biologically active thyroid hormone. This points toward a potential direct stimulatory effect of T3 on the cells that produce resistin.

Key Results

  • Overall Elevation: Patients with thyroid dysfunction had significantly higher resistin levels than euthyroid (normal) controls (MD = 2.11, $P < 0.00001$).
  • Subgroup Specifics:
    • Hyperthyroidism: MD = 3.23 ($P = 0.01$).
  • Subclinical Hypothyroidism: MD = 1.37 ($P = 0.01$).
  • Post-Treatment Drop: After treatment, resistin levels fell by an average of 1.00 unit ($P = 0.003$). In the hyperthyroidism subgroup specifically, the drop was even more pronounced (MD = 2.16, $P = 0.0003$).
  • Inflammatory Link: The authors suggest that the elevated resistin in these patients may contribute to the systemic low-grade inflammation and insulin resistance often seen in thyroid disorders.

Limitations and Future Work

The authors acknowledge several hurdles that still need to be cleared:

  • High Heterogeneity: There was significant statistical "noise" ($I^2$ values were high in several analyses), likely due to differences in resistin detection methods (ELISA vs. EIA), storage conditions, and patient demographics.
  • Small Subgroups: There was only one study available for subclinical hyperthyroidism, making it impossible to draw firm conclusions for that specific condition.
  • Observational Nature: While the study shows a strong association, it cannot prove causality. It remains unclear exactly how thyroid hormones trigger resistin release at the cellular level in humans.
  • Future Directions: The authors call for larger, multi-center longitudinal studies with more ethnically diverse populations to validate resistin’s potential as a clinical diagnostic marker or therapeutic target.

Summary updated

Abstract

https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022336617.
BibTeX
@inproceedings{zhou2023association,
  author = {Lin Zhou and Kang Song and Wei Luo},
  title = {{Association between circulating resistin levels and thyroid dysfunction: A systematic review and meta-analysis}},
  booktitle = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2022.1071922},
}
Figure